Skip To Main Content
Luis Pérez-Bartivas on Muck Rack

Luis Pérez-Bartivas

As seen in: UroToday
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Luis

Contact Luis, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Immunohistochemistry-Based Molecular Subtyping in Muscle-Invasive Bladder Cancer: Predicting Response to Neoadjuvant Chemotherapy.

|
By Luis Pérez-Bartivas, Fernando Leiva-Cepas, David Ponferrada
| UroToday Verified
Muscle-invasive bladder cancer (MIBC) presents a heterogeneous response to perioperative chemotherapy. Although several molecular classifications of MIBC have been proposed, two main subtypes, namely, luminal and basal, are widely recognised. This study aims to explore the relationship between the molecular subtypes of MIBC, as characterised by GATA binding protein 3 (GATA3) and cytokeratin 5/6 (CK5/6) immunohistochemistry, and treatment response to neoadjuvant chemotherapy.
Open in Who Shared Issue with article?
See all 1 articles